Results 41 to 50 of about 17,790 (205)

Maculopapular delayed exanthema due to ranitidine

open access: yes, 2020
Ranitidine is a widely used drug in Europe and its intake is usually well tolerated. Hypersensitivity reactions due to ranitidine are uncommon. The immediate mild reactions type are the most prevalent.
Teófilo Lobera Labairu   +5 more
core   +1 more source

Ranitidine and Thrombocytopenia

open access: yes, 1995
Objective: To provide an overview of thrombocytopenia, focusing on ranitidine-induced thrombocytopenia. Data Sources: References were selected from published bibliographies of books, case reports, and topical searches in the MEDLINE database (English ...
Jerry L Frazier, Josephine M Yim
core   +1 more source

The effect of mild and moderate hepatic impairment on the pharmacokinetics, safety and tolerability of balcinrenone

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Balcinrenone (previously AZD9977) is a novel selective non‐steroidal mineralocorticoid receptor antagonist (MRA) with a differential mechanism of action relative to approved MRAs. The aim of this trial was to assess the pharmacokinetics, safety and tolerability of balcinrenone in participants with mild and moderate hepatic impairment ...
Anna L. Eriksson   +8 more
wiley   +1 more source

Ranitidine bismuth(III) citrate

open access: yes, 1995
A variety of amines have been shown to solubilize bismuth(III) citrate, [Bi(Hcit)], and the nature of the adduct 1 between it and ranitidine [N,N-dimethyl-5-(3-nitromethylene-7-thia-2,4-diazaoctyl)furan-2-methanamine], which is currently on clinical ...
Sadler, PJ, Sun, H
core   +1 more source

Gastroprotective and Antioxidant Effects of Montelukast on Indomethacin-Induced Gastric Ulcer in Rats

open access: yesJournal of Pharmacological Sciences, 2007
Montelukast, a selective reversible cysteinyl leukotriene D4-receptor (LTD4 receptor) antagonist, is used in the treatment of asthma. We have investigated alterations in the glutathione (GSH) and activity levels of antioxidative enzymes [superoxide ...
Gunnur Ozbakis Dengiz   +4 more
doaj   +1 more source

Combined Use of Negative Oral Contrast and Ranitidine for Magnetic Resonance Cholangiopancreatography: A Randomized Controlled Trial

open access: yesJournal of Gastrointestinal and Abdominal Radiology, 2023
Objective Magnetic resonance cholangiopancreatography (MRCP) is a noninvasive imaging modality to study pancreaticobiliary tree. The primary aim of this study was to compare the image quality of MRCP obtained with the use of ferric ammonium chloride ...
Aravintho Natarajan   +5 more
doaj   +1 more source

Current practice and guideline adherence in renal dose adjustment for patients with chronic kidney disease: A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims To quantify prescribing adherence to renal dosing recommendations in adults with chronic kidney disease (CKD; Stage 3 and above) and to evaluate the clinical consequences of non‐adherence. Methods This systematic review and meta‐analysis was conducted in accordance with PRISMA 2020 guidelines and registered in PROSPERO (CRD42025620883).
Hager ElGeed   +7 more
wiley   +1 more source

Spectrophotometric determination of ranitidine hydrochloride and famotidine using 1,2- naphthoquinone-4-sulphonate

open access: yesZagazig Journal of Pharmaceutical Sciences, 2013
Accurate, simple and sensitive spectrophotometric method was developed for the determination of ranitidine hydrochloride and famotidine in bulk and pharmaceutical dosage forms.
Mohamed Elsadek   +3 more
doaj   +1 more source

NDMA formation by chloramination of ranitidine: Kinetics and mechanism [PDF]

open access: yes, 2012
The kinetics of decomposition of the pharmaceutical ranitidine (a major precursor of NDMA) during chloramination was investigated and some decomposition byproducts were identified by using high performance liquid chromatography coupled with mass ...
H. Gallard (23301709)   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy